Anders HJ - Search Results

1

A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas^lpr mice with proliferative lupus nephritis predicts low effect size.

Lei Y, Sehnert B, Voll RE, Jacobs-Cachá C, Soler MJ, Sanchez-Niño MD, Ortiz A, Bülow RD, Boor P, Anders HJ. Lei Y, et al. Among authors: anders hj. Kidney Int. 2021 Jun;99(6):1331-1341. doi: 10.1016/j.kint.2021.01.024. Epub 2021 Feb 16. Kidney Int. 2021. PMID: 33607177 Free article. Clinical Trial.

2

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.

Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D. Anders HJ, et al. J Am Soc Nephrol. 2004 Jun;15(6):1504-13. doi: 10.1097/01.asn.0000130082.67775.60. J Am Soc Nephrol. 2004. PMID: 15153561

3

CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.

Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Gröne HJ, Schlöndorff D, Anders HJ. Vielhauer V, et al. Among authors: anders hj. Kidney Int. 2004 Dec;66(6):2264-78. doi: 10.1111/j.1523-1755.2004.66038.x. Kidney Int. 2004. PMID: 15569315 Free article.

4

Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.

Kulkarni O, Pawar RD, Purschke W, Eulberg D, Selve N, Buchner K, Ninichuk V, Segerer S, Vielhauer V, Klussmann S, Anders HJ. Kulkarni O, et al. Among authors: anders hj. J Am Soc Nephrol. 2007 Aug;18(8):2350-8. doi: 10.1681/ASN.2006121348. Epub 2007 Jul 11. J Am Soc Nephrol. 2007. PMID: 17625118

5

Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.

Kulkarni O, Eulberg D, Selve N, Zöllner S, Allam R, Pawar RD, Pfeiffer S, Segerer S, Klussmann S, Anders HJ. Kulkarni O, et al. Among authors: anders hj. J Pharmacol Exp Ther. 2009 Feb;328(2):371-7. doi: 10.1124/jpet.108.142711. Epub 2008 Nov 7. J Pharmacol Exp Ther. 2009. PMID: 18997060

6

Interferon-alpha and -beta in kidney inflammation.

Anders HJ, Lichtnekert J, Allam R. Anders HJ, et al. Kidney Int. 2010 May;77(10):848-54. doi: 10.1038/ki.2010.71. Epub 2010 Mar 17. Kidney Int. 2010. PMID: 20237459 Free article. Review.

7

Innate immune receptors and autophagy: implications for autoimmune kidney injury.

Anders HJ, Schlondorff DO. Anders HJ, et al. Kidney Int. 2010 Jul;78(1):29-37. doi: 10.1038/ki.2010.111. Epub 2010 Apr 28. Kidney Int. 2010. PMID: 20428100 Free article. Review.

8

Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.

Kulkarni OP, Ryu M, Kantner C, Sárdy M, Naylor D, Lambert D, Brown R, Anders HJ. Kulkarni OP, et al. Among authors: anders hj. Nephrol Dial Transplant. 2012 Apr;27(4):1358-67. doi: 10.1093/ndt/gfr544. Epub 2011 Oct 10. Nephrol Dial Transplant. 2012. PMID: 21987536

9

Immunopathology of lupus nephritis.

Anders HJ, Fogo AB. Anders HJ, et al. Semin Immunopathol. 2014 Jul;36(4):443-59. doi: 10.1007/s00281-013-0413-5. Epub 2014 Jan 9. Semin Immunopathol. 2014. PMID: 24402709 Review.

10

IL-3 contributes to development of lupus nephritis in MRL/lpr mice.

Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, Schlossmann J, Brühl H, Anders HJ, Mack M. Renner K, et al. Among authors: anders hj. Kidney Int. 2015 Nov;88(5):1088-98. doi: 10.1038/ki.2015.196. Epub 2015 Jul 1. Kidney Int. 2015. PMID: 26131743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters